CIPLANSECipla Limited· PharmaceuticalsMediumNeutral
Announced Mon, 30 Mar · 18:19 IST

Cipla Limited has informed the Exchange about change in Management

Ceo ResignedManagement Changes View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹1222.00
prior close
₹1255.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-1.1-1.1-1.5-2.2-1.5-1.6-0.4+0.2-0.8+6.1+9.2+14.1+19.1
Up moveDown movePending
AI summary

Cipla's Board has announced a leadership transition effective April 1, 2026. Mr Umang Vohra will step down as Managing Director and Global CEO upon completion of his term on March 31, 2026, and has resigned as a Director from April 1, 2026. Mr Achin Gupta will take over as the new Managing Director and Global Chief Executive Officer. Additionally, two senior officials reporting directly to the new CEO — Mr Saurabh Gambhir (Head – Strategy and M&A, Global) and Mr Satyavan Manikani (Chief Portfolio Head, Global) — have been categorized as Senior Management Personnel of the company.

Likely market impact

This appears to be a planned and orderly CEO succession rather than a sudden exit, which should be viewed neutrally by investors. The transition brings a new leadership team at the top of India's third-largest pharma company, and shareholders will watch how the new CEO executes on growth strategy in the coming quarters.